Home LiteratureArticle Details
PMID: 18628403 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug).

Molecular pharmacology ·Vol. 74 ·No. 4 ·2008-10-00 ·Pages 1119-31

Nawaratne V, Leach K, Suratman N, Loiacono RE, Felder CC, Armbruster BN, Roth BL, Sexton PM, Christopoulos A

Abstract

The M4 muscarinic acetylcholine (ACh) receptor (mAChR) is a potential therapeutic target but characterized by a lack of subtype-selective ligands. We recently generated "designer receptors exclusively activated by a designer drug" (DREADDs), which contained mutations of two conserved orthosteric-site residues (Y113C/A203G in the M4 mAChR) that caused a loss of ACh activity but a gain in responsiveness to clozapine-N-oxide (CNO). The current study characterized the interactions of the wild type and the M4 DREADD with a range of agonists, antagonists, and the recently discovered M4 mAChR allosteric potentiator, 3-amino-5-chloro-6-methoxy-4-methyl-thieno[2,3-b]pyridine-2-carboxylic acid cyclopropylamide (LY2033298). LY2033298 displayed positive binding cooperativity with ACh, neutral cooperativity with the antagonist, [3H]quinuclidinyl benzilate, and agonism for activation of phosphorylated extracellular signal-regulated kinase (ERK) 1/2 at the wild-type M4 mAChR. LY2033298's cooperativity with clozapine or CNO was weakly positive with respect to binding but profoundly negative with respect to LY2033298 signaling. Although the DREADD mutations increased the binding and function of clozapine-like compounds, all other agonists lost the ability to activate the mutant; for the orthosteric agonists ACh and pilocarpine, this was due partly to a reduced affinity, whereas the affinity of LY2033298 or the atypical agonist 4-I-[3-chlorophenyl]carbamoyloxy)-2-butynyltrimethylammnonium chloride was unaltered. The interaction between LY2033298 and clozapine-like compounds reverted to neutral cooperativity on the DREADD, whereas LY2033298 caused a striking functional rescue of ACh potency and efficacy at the DREADD. These results provide conclusive evidence for the retention of a functional allosteric site on the M4 DREADD and highlight a role for residues Tyr113 and Ala203 in the transmission of cooperativity.

MeSH Terms
Acetylcholine/chemistry,metabolism,pharmacology Allosteric Regulation/physiology Allosteric Site/physiology Animals CHO Cells Clozapine/analogs & derivatives,chemistry,metabolism,pharmacology Cricetinae Cricetulus Dose-Response Relationship, Drug Enzyme Activation/drug effects Mitogen-Activated Protein Kinase 1/metabolism Mitogen-Activated Protein Kinase 3/metabolism Models, Biological Molecular Structure Mutation Nicotinic Acids/chemistry,genetics,metabolism,pharmacology Phosphorylation/drug effects Quinuclidinyl Benzilate/metabolism,pharmacology Radioligand Assay Receptor, Muscarinic M4/agonists,antagonists & inhibitors,physiology Signal Transduction Thiophenes/chemistry,metabolism,pharmacology
Chemicals
3-amino-5-chloro-6-methoxy-4-methyl-thieno(2,3-b)pyridine-2-carboxylic acid cyclopropylamide Nicotinic Acids Receptor, Muscarinic M4 Thiophenes Quinuclidinyl Benzilate Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3 Clozapine clozapine N-oxide Acetylcholine
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Nawaratne Vindhya
Drug Discovery Biology Laboratory, Monash Institute of Pharmaceutical Sciences, Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia.
Leach Katie
Suratman Nur
Loiacono Richard E
Felder Christian C
Armbruster Blaine N
Roth Bryan L
Sexton Patrick M
Christopoulos Arthur
Article Info
Journal
Molecular pharmacology
Abbr.
Mol Pharmacol
ISSN
1521-0111
Published
2008-10-00
Epub
2008-00-15
Pages
1119-31
Language
English
Region
United States
NLM ID
0035623
Subset
IM
Grants
NIMH NIH HHS · U19 MH082441 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]